A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this open-label study is to investigate the interaction of
ketoconazole, a liver enzyme inhibitor, on oral LBH589 in adult patients with advanced solid
tumors. The extension phase of the study will evaluate the safety and efficacy of LBH589 in
patients with advanced solid tumors.